ArraVasc Overview
- Year Founded
-
2004
- Status
-
Out of Business
- Employees
-
39
- Latest Deal Type
-
Out of Business
ArraVasc General Information
Description
Developer of catheters designed to treat Coronary Artery Disease (CAD) and bifurcation vascular disease. The company's catheters are drug-eluting ostium protection devices for the treatment of coronary artery lesions located at a bifurcation and ostium, enabling healthcare providers to treat coronary artery diseases.
Contact Information
Website
www.arravasc.comCorporate Office
- 2 Ballybrit Business Park
- Galway H91 DT7C
- Ireland
Corporate Office
- 2 Ballybrit Business Park
- Galway H91 DT7C
- Ireland
ArraVasc Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Out of Business | 13-May-2018 | Completed | Out of Business | |||
| 6. Later Stage VC | 01-Jan-2017 | Completed | Generating Revenue | |||
| 5. Secondary Transaction - Private | 12-Mar-2015 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series D) | 21-Feb-2011 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series C) | 15-Jun-2009 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 01-Jan-2007 | $4.94M | $13.2M | Completed | Generating Revenue | |
| 1. Early Stage VC | $8.25M | $8.25M | Completed | Startup |
ArraVasc Comparisons
Industry
Financing
Details
ArraVasc Competitors (5)
One of ArraVasc’s 5 competitors is Elliquence, a Corporate Backed or Acquired company based in Baldwin, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Elliquence | Corporate Backed or Acquired | Baldwin, NY | ||||
| CathRX | Venture Capital-Backed | Sydney, Australia | ||||
| Kardium | Private Equity-Backed | Burnaby, Canada | ||||
| CardioFocus | Venture Capital-Backed | Marlborough, MA | ||||
| Asensus Surgical | Formerly VC-backed | Durham, NC |
ArraVasc Patents
ArraVasc Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-11338115-B2 | Finned angioplasty balloon | Active | 30-Sep-2016 | ||
| US-20190344054-A1 | Finned angioplasty balloon | Active | 30-Sep-2016 | ||
| WO-2018060466-A1 | Finned angioplasty balloon | Inactive | 30-Sep-2016 | ||
| EP-3307372-A1 | A delivery system for a drug coated angioplasty balloon | Inactive | 12-Jun-2015 | ||
| WO-2016198670-A1 | A delivery system for a drug coated angioplasty balloon | Inactive | 12-Jun-2015 | A61M25/104 |
ArraVasc Signals
ArraVasc FAQs
-
When was ArraVasc founded?
ArraVasc was founded in 2004.
-
Where is ArraVasc headquartered?
ArraVasc is headquartered in Galway, Ireland.
-
What is the size of ArraVasc?
ArraVasc has 39 total employees.
-
What industry is ArraVasc in?
ArraVasc’s primary industry is Surgical Devices.
-
Is ArraVasc a private or public company?
ArraVasc is a Private company.
-
What is ArraVasc’s current revenue?
The current revenue for ArraVasc is .
-
How much funding has ArraVasc raised over time?
ArraVasc has raised $59.9M.
-
Who are ArraVasc’s competitors?
Elliquence, CathRX, Kardium, CardioFocus, and Asensus Surgical are competitors of ArraVasc.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process